Medical Polymers Market detail insight to 2024 Focusing on key players like Bayer AG, Evonik Industries, Celanese, DuPont, Dow Chemical and Huntsman

Companies operating in global medical polymers market adopt varied business strategies such as collaborations, R&D investments, and mergers & acquisitions to sustain their position. This industry is highly fragmented and involves the partaking of myriad local medium and large-sized businesses. Major players operating in medical polymers market include Evonik Industries, DuPont, Huntsman, Bayer AG, Dow Chemicals, Celanese Corporation, and Eastman Chemicals. Medical polymers market firms constantly strive to upgrade their product portfolio and improve their service sphere to score an edge over competitors.

Request for a sample copy of this report @
www.gminsights.com/request-sample/detail/1126

The healthcare sector has observed a paradigm shift since the last few years, subject to which Medical Polymers Market will depict a lucrative growth path. Of late, there has been a spur in the prevalence of chronic ailments such as cardiovascular disorders, infections, hypertension, dementia, osteoporosis, and arthritis, thereby boosting global pharmaceutical and healthcare sectors, which are key drivers propelling medical polymers market. The ever-growing geriatric population across the globe and the rising awareness regarding efficient medical devices and equipment will also fuel medical polymers industry, set to cross a valuation of USD 24 billion by 2024, with a CAGR estimation of 9% over 2016-2024.

Recently, at K 2016, the world’s largest plastics fair, Celanese Corporation showcased their range of reliable, safe, and compliant medical polymers that acknowledge issues such as dosage frequency and patient compliance. These polymers, when incorporated in medical devices & equipment, were designed to depict high performance, distinguishable appearance, and efficient operational ability. With many other companies undertaking similar efforts to develop high grade polymers for easy and safe treatment admission, global medical polymers industry size is set to rise a notch higher.

Global pharmaceutical device market was valued over USD 300 billion in 2015 and is anticipated to register a notable CAGR of more than 6% over the next seven years. U.S. held more than 45% of this share in 2015, subject to which pharmaceutical device industry from the U.S. is estimated to grow remarkably over the next few years. This will significantly propel U.S. medical polymers market as well.

Browse Complete Report Summary @
www.gminsights.com/industry-analysis/medical-polymers-market

Medical elastomers, another key product segment of medical polymers market, is further categorized into rubber latex and styrene block copolymers. This segment is expected to grow lucratively over 2016-2024. Fibers and resins include sub-products such as polypropylene (PP), polystyrene (PS), polyvinyl chloride (PVC), and polyethylene (PE). Medical polymers industry from fibers & resins was valued at USD 8 billion in 2015, and is anticipated to grow at a CAGR of 8% over 2016-2024. This growth can be credited to the rising awareness pertaining to health and hygiene, and the introduction of innovative technologies to adjust implant capabilities.

The production of medical polymers is largely dependent on the availability of raw materials. Owing to depleting fossil fuel availability and petroleum reserves, there may be a dramatic shift on the prices of raw materials, which is forecast to be one of the chief restraints of medical polymers market. Additionally, the prominent medical agencies such as FDA, WHO, and REACH have mandated regulations regarding the product prices and quality, which is also likely to hamper the growth of this industry.

Partial Chapter of the Table of Content
Chapter 2 Executive Summary
2.1 Medical Polymers Market 3600 synopsis, 2013 – 2024
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 Regional trends

Make an inquiry for purchasing this report @
www.gminsights.com/inquiry-before-buying/1126

Chapter 3 Medical Polymers Industry Insights
3.1 Industry segmentation
3.2 Industry size & growth forecast, 2013 – 2024
3.3 Industry ecosystem analysis
3.3.1 Vendor matrix
3.3.2 Distributor matrix
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Growing pharmaceutical devices market
3.4.1.2 Increasing geriatric population and consequential medical treatments
3.4.1.3 Changing trends towards home health care treatment
3.4.2 Industry pitfalls and challenges
3.4.2.1 Inconsistent raw material prices
3.4.2.2 Stringent regulations to govern new products
3.5 Growth potential analysis
3.6 Regulatory trends
3.6.1 U.S.
3.6.2 Europe
3.6.3 China
3.7 Porter’s analysis
3.8 Company market share analysis, 2015
3.7.1 Strategic landscape
3.9 PESTEL analysis
3.10 Regional price trends
3.10.1 Cost structure analysis
3.10.2 Raw material trends

About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com

This release was published on openPR.